YAP1 and lung carcinoma: YAP1 has also been reported to mediate survival in a study by Tsuji et al. They showed that YAP1 was activated in alectinib-treated ALK-rearranged lung cancer cells and bound to MCL1 and BCLXL upstream regions, thus increasing the expression of the two anti-apoptotic genes [120].